BioNotebook: Versant raises $305m venture fund; plus deal notes from Pfizer/iTeos, Juno/Opus, CHI/BayBio
Versant Ventures closed its fifth health care-focused venture capital fund with a $305m total that exceeded the San Francisco-based firm's $250m goal.